ストックスクリーナーアプリを入手
0.484
2.81%
-0.014
アフターアワーズ：
.48
-0.004
-0.83%
前日終値:
$0.498
開ける：
$0.4912
24時間の取引高:
178.45K
Relative Volume:
0.49
時価総額：
$12.10M
収益：
-
当期純損益:
$-34.10M
株価収益率:
-0.327
EPS:
-1.48
ネットキャッシュフロー:
$-32.20M
1週間 パフォーマンス:
+4.74%
1か月 パフォーマンス:
-37.95%
6か月 パフォーマンス:
-65.43%
1年 パフォーマンス:
-26.64%
1日の値動き範囲:
$0.4689
$0.509
1週間の範囲:
$0.4318
$0.55
52週間の値動き範囲:
$0.384
$1.94
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
名前
Sensei Biotherapeutics Inc
セクター
電話
(240) 243-8000
住所
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
SNSE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| SNSE | 0.484 | 12.10M | 0 | -34.10M | -32.20M | -1.48 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-01 | ダウングレード | Berenberg | Buy → Hold |
| 2021-06-29 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-03-01 | 開始されました | Berenberg | Buy |
| 2021-03-01 | 開始されました | Citigroup | Buy |
| 2021-03-01 | 開始されました | Oppenheimer | Outperform |
| 2021-03-01 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Sensei Biotherapeutics Inc (SNSE) 最新ニュース
Sensei Biotherapeutics Q3 2024 Results and Strategic Moves - TipRanks
Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace
Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Sensei Biotherapeutics Inc. (SNSE) Quarterly 10-Q Report - Quartzy
Sensei Bio Cuts 46% of Workforce, Extends Cash Runway to 2026 Amid Restructuring | SNSE Stock News - StockTitan
Sensei Biotherapeutics Inc (SNSE) Quarterly 10-Q Report - Quartzy
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewswire
3 US Penny Stocks To Monitor In October 2024 - Yahoo Finance Australia
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.01% - MSN
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Up 6% - Defense World
Sensata Technologies Holding plc (NYSE:ST) Stock Holdings Trimmed by Mutual of America Capital Management LLC - Defense World
SeQuent Scientific hits 52-week high, surges nearly 9% in 20 minutes - Business Upturn
SENS Stock on the Rise: A Promising Investment - The InvestChronicle
Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times
Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY
Sensiva Health names Ben Williamson as Chief Executive Officer - WV News
Recent Insider Activity Could Benefit Sensata Technologies Holding Plc (ST) - Knox Daily
Is Seelos Therapeutics Inc (SEEL) worth investing in despite its undervalued state? - US Post News
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
46,650 Shares in Sensata Technologies Holding plc (NYSE:ST) Purchased by Schwerin Boyle Capital Management Inc. - Defense World
Trend Tracker for (ST) - Stock Traders Daily
Benjamin Edwards Inc. Buys 169 Shares of Standex International Co. (NYSE:SXI) - Defense World
Sensei Biotherapeutics names new financial chief - Investing.com India
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com - Defense World
Sensei Biotherapeutics Appoints New Financial Chief - TipRanks
Are Smart Investors Making the Right Decision? Sensata Technologies Holding Plc (ST) - SETE News
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensei Biotherapeutics names new financial chief By Investing.com - Investing.com South Africa
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Multibagger Alert: Senco Gold Stock Soars 300% Since IPO – Is More Growth on the Horizon? Analysts Weigh In! - Share Price India News
SYSTM Wealth Solutions LLC Lowers Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sensei Biotherapeutics’ SNS-103 shows pH-dependent antitumor efficacy - BioWorld Online
Massachusetts Financial Services Co. MA Sells 444,049 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
There is no doubt that Seelos Therapeutics Inc (SEEL) ticks all the boxes. - SETE News
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? - MSN
ST Stock Sees Surge of Approximately 2.46% in Last Five Days - Knox Daily
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? | Stock Market News - Mint
Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
Seelos Therapeutics Inc (SEEL) Stock: A Comprehensive 52-Week Review - The InvestChronicle
American Century Companies Inc. Cuts Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Seneca Foods (NASDAQ:SENEA) Share Price Crosses Above 200-Day Moving Average of $58.33 - MarketBeat
Texas Permanent School Fund Corp Has $1.97 Million Holdings in StoneX Group Inc. (NASDAQ:SNEX) - Defense World
StoneX Group (NASDAQ:SNEX) Hits New 12-Month High at $84.40 - MarketBeat
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Perhaps timely catching Senseonics Holdings Inc (SENS) would be a good idea - SETE News
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Texas Permanent School Fund Corp Sells 19,179 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensei Biotherapeutics Inc (SNSE) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):